Giovanni Graziano

Dr. Giovanni Graziano

Pharmacy-Sciences of Drugs, University of Bari Aldo Moro, Bari, Puglia, Italy
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Giovanni GrazianoGiovanni Graziano
Giovanni Graziano
ASAngela Stefanachi
Angela Stefanachi
Marialessandra ContinoMarialessandra Contino
Marialessandra Contino
RPRubén Prieto-Díaz
Rubén Prieto-Díaz
Alessia LigrestiAlessia Ligresti
Alessia Ligresti
FLFrancesco Leonetti
Francesco Leonetti
Multicomponent reactions (MCRs) have emerged as a powerful strategy in synthetic organic chemistry due to their widespread applications in drug discovery and development. MCRs are flexible transformations in which three or more substrates react to form structurally complex products with high atomic efficiency. They are being increasingly appreciated as a highly exploratory and evolutionary tool by the medicinal chemistry community, opening the door to more sustainable, cost-effective and rapid synthesis of biologically active molecules. In recent years, MCR-based synthetic strategies have found extensive application in the field of drug discovery, and several anticancer drugs have been synthesized through MCRs. In this review, we present an overview of representative and recent literature examples documenting different approaches and applications of MCRs in the development of new anticancer drugs.

16 April 2024 in Computers in Biology and Medicine
Verified
Journal Article
Open access
DADomenico Alberga
Domenico Alberga
GLGiuseppe Lamanna
Giuseppe Lamanna
Giovanni GrazianoGiovanni Graziano
Giovanni Graziano
PDPietro Delre
Pietro Delre
MLMaria Cristina Lomuscio
Maria Cristina Lomuscio
GMGiuseppe Felice Mangiatordi
Giuseppe Felice Mangiatordi
In this paper, we introduce DeLA-DrugSelf, an upgraded version of DeLA-Drug [J. Chem. Inf. Model. 62 (2022) 1411-1424], which incorporates essential advancements for automated multi-objective de novo design. Unlike its predecessor, which relies on SMILES notation for molecular representation, DeLA-DrugSelf employs a novel and robust molecular representation string named SELFIES (SELF-referencing Embedded String). The generation process in DeLA-DrugSelf not only involves substitutions to the initial string representing the starting query molecule but also incorporates insertions and deletions. This enhancement makes DeLA-DrugSelf significantly more adept at executing data-driven scaffold decoration and lead optimization strategies. Remarkably, DeLA-DrugSelf explicitly addresses the SELFIES-related collapse issue, considering only collapse-free compounds during generation. These compounds undergo a rigorous quality metrics evaluation, highlighting substantial advancements in terms of drug-likeness, uniqueness, and novelty compared to the molecules generated by the previous version of the algorithm. To evaluate the potential of DeLA-DrugSelf as a mutational operator within a genetic algorithm framework for multi-objective optimization, we employed a fitness function based on Pareto dominance. Our objectives focused on target-oriented properties aimed at optimizing known cannabinoid receptor 2 (CB2R) ligands. The results obtained indicate that DeLA-DrugSelf, available as a user-friendly web platform (https://www.ba.ic.cnr.it/softwareic/delaself/), can effectively contribute to the data-driven optimization of starting bioactive molecules based on user-defined parameters.

29 March 2023 in Advanced Materials Interfaces
Verified
Journal Article
Open access
LSLucia Sarcina
Lucia Sarcina
PDPietro Delre
Pietro Delre
Giovanni GrazianoGiovanni Graziano
Giovanni Graziano
ASAngela Stefanachi
Angela Stefanachi
DBDavide Blasi
Davide Blasi
Luisa TorsiLuisa Torsi
Luisa Torsi
A plethora of different electronic and optoelectronic devices have been developed lately, for biosensing applications (e.g., label‐free, fast, and easier to operate) based on a detecting interface accommodating the biorecognition elements, anchored by thiolate self‐assembled monolayers (SAMs) on a gold surface. Here, a surface plasmon resonance (SPR) characterization of anti‐p24 anchored on different SAMs is performed to investigate the effect of the SAM structure on the antibodies’ packing efficiency and the sensors’ analytical figures of merit. Notably, the mixed SAM deposited from a solution 10:1 of 3‐mercaptopropionic acid and 11‐mercaptoundecanoic acid (11MUA) is compared to that resulting from a solution 10:1 of ad hoc synthesized N‐(2‐hydroxyethyl)‐3‐mercaptopropanamide (NMPA)/11MUA. Despite the improvement in the anti‐p24 surface coverage registered using the 11MUA/NMPA SAM, the latter produces a significant decrease in the antibodies’ binding efficiency against human immunodeficiency virus p24 protein. To provide a molecular rationale behind the SPR data, density functional theory calculations are also undertaken. A comprehensive physical view of the main competing phenomena affecting the biorecognition events at a biofunctionalized gold detecting interface is represented here.

13 January 2023 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Giovanni GrazianoGiovanni Graziano
Giovanni Graziano
PDPietro Delre
Pietro Delre
FCFrancesca Carofiglio
Francesca Carofiglio
JBJosè Brea
Josè Brea
ALAlessia Ligresti
Alessia Ligresti
FLFrancesco Leonetti
Francesco Leonetti

14 March 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Francesco SamarelliFrancesco Samarelli
Francesco Samarelli
Giovanni GrazianoGiovanni Graziano
Giovanni Graziano
Nicola GambacortaNicola Gambacorta
Nicola Gambacorta
EGElisabetta Anna Graps
Elisabetta Anna Graps
FLFrancesco Leonetti
Francesco Leonetti
Cosimo D. AltomareCosimo D. Altomare
Cosimo D. Altomare
People affected by COVID-19 are exposed to, among others, abnormal clotting and endothelial dysfunction, which may result in deep vein thrombosis, cerebrovascular disorders, and ischemic and non-ischemic heart diseases, to mention a few. Treatments for COVID-19 include antiplatelet (e.g., aspirin, clopidogrel) and anticoagulant agents, but their impact on morbidity and mortality has not been proven. In addition, due to viremia-associated interconnected prothrombotic and proinflammatory events, anti-inflammatory drugs have also been investigated for their ability to mitigate against immune dysregulation due to the cytokine storm. By retrieving patent literature published in the last two years, small molecules patented for long-COVID-related blood clotting and hematological complications are herein examined, along with supporting evidence from preclinical and clinical studies. An overview of the main features and therapeutic potentials of small molecules is provided for the thromboxane receptor antagonist ramatroban, the pan-caspase inhibitor emricasan, and the sodium–hydrogen antiporter 1 (NHE-1) inhibitor rimeporide, as well as natural polyphenolic compounds.

12 August 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
CGClaudia Gioé-Gallo
Claudia Gioé-Gallo
SOSandra Ortigueira
Sandra Ortigueira
RPRubén Prieto-Díaz
Rubén Prieto-Díaz
Marialessandra ContinoMarialessandra Contino
Marialessandra Contino
JAJhonny Azuaje
Jhonny Azuaje
ESEddy Sotelo
Eddy Sotelo
This study presents the design, synthesis, and characterization of a novel series of structurally simple, selective, and functionally biased CB2 receptor (CB2R) agonists with potent anti-inflammatory and neuroprotective properties. These compounds were developed using a conformational restriction strategy to abolish CB1R binding, thereby enhancing CB2R selectivity. Pharmacological profiling identified ligands with distinct bias toward β-arrestin, MAPK, and G-protein signaling pathways. The series exhibits favorable drug-like properties, including high BBB permeability, low P-glycoprotein interaction, and microsomal stability. Representative compounds demonstrated neuroprotective activity in mouse primary neuronal assays and significantly reduced ROS and caspase levels in vitro, indicating mitigation of oxidative stress and apoptosis. In a neuron-like SH-SY5Y model expressing pathogenic mutations, they preserved neurite complexity in a CB2R-dependent manner. Collectively, these findings highlight the advantages of conformational restriction in transforming abused promiscuous, neurotoxic ligands into highly selective and efficacious agents for the treatment of neurodegenerative disorders, without CB1R-mediated psychoactive effects.